About Mithra Pharmaceuticals Cdmo
Mithra Pharmaceuticals Cdmo is a public limited company (NV/SA) based in Liège, founded in 2013. According to the company register, Mithra Pharmaceuticals Cdmo has the status "Opening faillissement". Its main activity is classified as "Vervaardiging van geneesmiddelen". For the 2022 financial year, Mithra Pharmaceuticals Cdmo reported a loss of €14.6 million. That makes 5 loss-making financial years in a row for Mithra Pharmaceuticals Cdmo. Revenue came to €26.7 million, down 21% on 2021. It employed an average of 153.6 full-time equivalents. Equity is negative (-€14.6 million): liabilities exceed assets. In 2014 it was -€952,358. 9 annual accounts are available, covering 2014 to 2022.
- Activities
- Signals
-
Juridical warningJuridical warning
The legal status points to elevated risk (e.g. dissolution or bankruptcy).
Negative equityNegative equity € -14.62MEquity is negative: debts exceed assets (technically insolvent).
Reporting lossesReporting losses € -9.98MThe company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.25The current ratio is below 1: may be insufficient to cover short-term debt.
Negative cashflowNegative cashflow € -8.17MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -3.55MEBITDA is negative: operating activities are loss-making.
High turnoverHigh turnover € 26.74MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 15.7%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
|
€
26.74M
|
€
33.74M
|
€
27.98M
|
€
22.65M
|
|
|
€
-3.55M
|
€
7.01M
|
€
7.32M
|
€
3.60M
|
|
|
€
-14.59M
|
€
-2.13M
|
€
-612K
|
€
-3.74M
|
|
|
€
-14.62M
|
€
350K
|
€
2.80M
|
€
3.66M
|
|
|
-16.92%
|
0.35%
|
2.59%
|
3.50%
|
|
|
€
101.05M
|
€
100.26M
|
€
105.32M
|
€
100.90M
|
|
|
€
516K
|
€
2.77M
|
€
1.39M
|
€
126K
|
|
|
153.60
|
168
|
128
|
85
|
Publications 19
All publications- Rubrique Fin (Cessation, Annulation Cessation, Nullite, Conc, Reorganisation Judiciaire, Etc...) 24/06/2024
- Demissions, Nominations 10/05/2024
- Demissions, Nominations 03/04/2024
- Capital, Actions - Demissions, Nominations 07/12/2023
- Demissions, Nominations 01/08/2023
Frequently asked questions
Answers to the most common questions about Mithra Pharmaceuticals Cdmo, based on official government data and the filed annual accounts.
What is the VAT number of Mithra Pharmaceuticals Cdmo?
The VAT number of Mithra Pharmaceuticals Cdmo is BE0534.912.933.
How many employees work at Mithra Pharmaceuticals Cdmo?
In 2022, Mithra Pharmaceuticals Cdmo employed 153.60 full-time equivalents (FTE).
When was Mithra Pharmaceuticals Cdmo established?
Mithra Pharmaceuticals Cdmo was founded in 04-06-2013.
What is the official address of Mithra Pharmaceuticals Cdmo?
The official address of Mithra Pharmaceuticals Cdmo is Rue Saint-Georges 5 Liège 4000.
What is the legal form of Mithra Pharmaceuticals Cdmo?
The juridical form of Mithra Pharmaceuticals Cdmo is Public limited company (NV/SA).
What is the annual revenue of Mithra Pharmaceuticals Cdmo?
The revenue of Mithra Pharmaceuticals Cdmo for the 2022 financial year was €26,744,702.
Is Mithra Pharmaceuticals Cdmo a reliable company?
Mithra Pharmaceuticals Cdmo is a registered Rechtspersoon with company number 0534.912.933 and can be verified through the official CBE database.
What is the credit limit of Mithra Pharmaceuticals Cdmo?
The estimated credit limit of Mithra Pharmaceuticals Cdmo is €803,233.
Is Mithra Pharmaceuticals Cdmo still active?
Mithra Pharmaceuticals Cdmo currently has the status "Opening faillissement" and is not active.